Compound ID | 786

Update compound information

A-63075

Class: Macrolide

Agent Type: Synthetic; Small molecule; Direct acting;
Mechanism of action: Protein synthesis inhibitor
Target Pathogen: Active against Mycoplasma sp.
Institute where first reported: Abbott Laboratories, USA
Year first mentioned: 1987
Development status: Experimental
Reason dropped: Activity was similar if not less potent than clarithromycin and erythromycin against Mycoplasma pneumoniae
Chemical structure(s):
Click here for structure editor
Molecular weight: 790.98
Iso. SMILES: CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)OC(=O)N)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
InChI Key: NAICHCWALKXCFL-UHFFFAOYSA-N
Can. SMILES: CCC1C(C)(C(C(C)C(=O)C(C)CC(C)(C(C(C)C(C(C)C(=O)O1)OC2CC(C)(C(C(C)O2)OC(=O)N)OC)OC3C(C(CC(C)O3)N(C)C)O)OC)O)O
InChI: InChI=1S/C39H70N2O14/c1-15-26-39(10,47)31(44)21(4)28(42)19(2)17-37(8,48-13)32(54-35-29(43)25(41(11)12)16-20(3)50-35)22(5)30(23(6)34(45)52-26)53-27-18-38(9,49-14)33(24(7)51-27)55-36(40)46/h19-27,29-33,35,43-44,47H,15-18H2,1-14H3,(H2,40,46)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/84022
Citation: https://doi.org/10.1128/aac.32.10.1500

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.